FDA approves Brytly, a nonprescription eye drop for eye redness
The FDA approved Brytly, apraclonidine ophthalmic solution 0.125%, for relief of eye redness due to minor irritations. The approval is the first nonprescription eye drop containing apraclonidine and is available to adults and children 12 years of age and older.
Primary source
FDA approval notification, October 16, 2026
FDA Approves New Nonprescription Eye Drop for Relief of Eye Redness
Read the source: FDA Approves New Nonprescription Eye Drop for Relief of Eye Redness fda.gov
Machine-summarized from the source above; not independently reported. How we use automation